Gynecology News and Research

RSS

Researchers design new questionnaire to improve knowledge of impact of menopause on women

A new questionnaire being developed through a collaboration between the Massachusetts General Hospital Midlife Women's Health Center and the North American Menopause Society is designed to improve knowledge of the extent and impact on women of genitourinary symptoms of menopause.

8 Jan 2019

Sexual function in women with vulva pain improved with oral nerve pain medication

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous herpes infection as well as fibromyalgia, according to a Rutgers study.

2 Jan 2019

Childbirth delivery mode linked with woman’s risk of developing pelvic floor disorders

Research completed at Johns Hopkins and the Greater Baltimore Medical Center has demonstrated that vaginal childbirth substantially increases the probability a woman will develop a pelvic floor disorder later in life.

20 Dec 2018

Research explores effects of cannabis use on males’ reproductive health

As legal access to marijuana continues expanding across the U.S., more scientists are studying the effects of its active ingredient, tetrahydrocannabinol (THC), in teens, adults and pregnant women.

19 Dec 2018

Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America

Hologic announced today the North American launch of the FDA-cleared TempSure Surgical RF technology, a new offering of the TempSure radiofrequency platform.

From Hologic, Inc. 18 Dec 2018

Early postpartum initiation of opioids associated with persistent use

Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum period, they are at increased risk of developing persistent opioid use.

18 Dec 2018

SLU researchers explore how fetal exposure to inflammation can alter immunity in newborns

Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth.

12 Dec 2018

Brigham researchers develop automated, low-cost tool to predict a woman's ovulation

Investigators from Brigham and Women's Hospital are developing an automated, low-cost tool to predict a woman's ovulation and aid in family planning.

11 Dec 2018

Study: Women with history of sexual trauma have clear preferences in obstetric care

One in five women in the United States will experience sexual trauma, yet no evidence-based guidelines exist to treat these women during pregnancy and childbirth.

30 Nov 2018

Report recommends creation of health monitoring, research program on Gulf War and post-9/11 veterans

To help determine if the descendants of Gulf War and post-9/11 veterans are at risk for health effects resulting from the service members' exposure to toxicants during deployment, a new report from the National Academies of Sciences, Engineering, and Medicine recommends the creation of a health monitoring and research program.

29 Nov 2018

Study finds increase in preconception health coverage after Medicaid expansion

The number of low-income women enrolled in Medicaid before becoming pregnant rose substantially in states that expanded Medicaid eligibility through the Affordable Care Act, according to researchers at Columbia University Mailman School of Public Health.

27 Nov 2018

Scientists identify three genes responsible for recurrent molar pregnancies

A team of scientists at the Research Institute of the McGill University Health Centre and McGill University have identified three genes responsible for recurrent molar pregnancies, a rare complication that occurs when a non-viable pregnancy with no embryo implants in the uterus.

20 Nov 2018

Cytocybernetics receives NIMH award to move into neuronal drug development

Cytocybernetics, a University at Buffalo spinoff, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

20 Nov 2018

Promising technology could improve detection, diagnosis of fatal ovarian cancer

Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women.

14 Nov 2018

Simple cysts can be safely ignored, study finds

Simple ovarian cysts are extremely common in women and do not require additional ultrasound surveillance or surgical removal, according to a new study of more than 72,000 women and close to 119,00 pelvic ultrasound exams over a dozen years.

12 Nov 2018

New oral drug reduces menstrual bleeding for women with common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

9 Nov 2018

Mailing self-collection HPV kits has potential to boost cervical cancer screening

University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer screening - especially for low-income women who are overdue for testing.

7 Nov 2018

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

1 Nov 2018

Infant birthweights found to be increasing in a series of pregnancies

A new Tel Aviv University study finds that neonatal birthweights increase in direct proportion with the number of births of the mother in at least 30 percent of all cases. The study focuses on the risk of having large for gestational age infants, babies who clock in at higher than the 90th percentile for weight.

31 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018